DiaMedica Therapeutics Inc.
DMAC
$6.05
$0.091.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.16% | 18.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.99% | 12.81% | |||
| Operating Income | -1.99% | -12.81% | |||
| Income Before Tax | -1.35% | -11.97% | |||
| Income Tax Expenses | 66.67% | 0.00% | |||
| Earnings from Continuing Operations | -1.39% | -11.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.39% | -11.96% | |||
| EBIT | -1.99% | -12.81% | |||
| EBITDA | -2.07% | -12.63% | |||
| EPS Basic | 4.03% | 3.07% | |||
| Normalized Basic EPS | 4.06% | 3.04% | |||
| EPS Diluted | 4.03% | 3.07% | |||
| Normalized Diluted EPS | 4.06% | 3.04% | |||
| Average Basic Shares Outstanding | 5.62% | 15.53% | |||
| Average Diluted Shares Outstanding | 5.62% | 15.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||